ProShares Ultra Health Care(RXL · ETF)
ETF quote, holdings, sector allocation, technicals, and options analytics.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
Snapshot
$49.72
- 52-Week Range
- $36.23 – $55.58
- YTD
- -4.82%
- IV Rank (30D)
- 39.52
- Straddle Price
- $4.70
- P/C Vol Ratio
- 2.75
Info
ProShares Ultra Health Care (RXL) ETF
- Exchange
- ARCX
- Inception
- 2007-01-30
- Has Options
- Yes
ETF Profile
holdings as of 2026-06-12
Holdings
66
AUM
$155.4M
Provider
ProShares
Inception
2007-01-30
Exchange
ARCX
Data As Of
2026-06-12
Expense Ratio
—
Dividend Yield
1.51%
Distribution
Quarterly
Recent distributions
| Ex-Date | Pay Date | Amount | Type |
|---|---|---|---|
| 2026-03-25 | 2026-03-31 | $0.1444 | CD |
| 2025-12-24 | 2025-12-31 | $0.1838 | CD |
| 2025-09-24 | 2025-09-30 | $0.2031 | CD |
| 2025-06-25 | 2025-07-01 | $0.2193 | CD |
| 2025-03-26 | 2025-04-01 | $0.1343 | CD |
| 2024-12-23 | 2024-12-31 | $0.1472 | CD |
Asset Allocation
Top Holdings
top 50 of 66 holdings
| Symbol | Name | Weight % | Asset Class | Country |
|---|---|---|---|---|
| — | HEALTH CARE SELECT SECTOR INDEX SWAP UBS AG | 26.02% | Derivative | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP BNP PARIBAS | 14.73% | Derivative | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 6.26% | Derivative | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP SOCIETE GENERALE | 5.81% | Derivative | — |
| LLY | ELI LILLY & CO | 5.78% | Equity (US) | — |
| IQMM | PROSHARES GENIUS MNY MKT ETF | 5.48% | Equity (US) | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP CITIBANK NA | 4.60% | Derivative | — |
| JNJ | JOHNSON & JOHNSON | 3.74% | Equity (US) | — |
| ABBV | ABBVIE INC | 2.59% | Equity (US) | — |
| UNH | UNITEDHEALTH GROUP INC | 2.37% | Equity (US) | — |
| MRK | MERCK & CO. INC. | 1.89% | Equity (US) | — |
| — | HEALTH CARE SELECT SECTOR INDEX SWAP BANK OF AMERICA NA | 1.43% | Derivative | — |
| AMGN | AMGEN INC | 1.23% | Equity (US) | — |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.13% | Equity (US) | — |
| GILD | GILEAD SCIENCES INC | 1.00% | Equity (US) | — |
| ABT | ABBOTT LABORATORIES | 0.99% | Equity (US) | — |
| PFE | PFIZER INC | 0.96% | Equity (US) | — |
| ISRG | INTUITIVE SURGICAL INC | 0.94% | Equity (US) | — |
| CVS | CVS HEALTH CORP | 0.84% | Equity (US) | — |
| BMY | BRISTOL-MYERS SQUIBB CO | 0.75% | Equity (US) | — |
| DHR | DANAHER CORP | 0.73% | Equity (US) | — |
| VRTX | VERTEX PHARMACEUTICALS INC | 0.73% | Equity (US) | — |
| SYK | STRYKER CORP | 0.69% | Equity (US) | — |
| MDT | MEDTRONIC PLC | 0.66% | Equity (US) | — |
| MCK | MCKESSON CORP | 0.62% | Equity (US) | — |
| ELV | ELEVANCE HEALTH INC | 0.57% | Equity (US) | — |
| CI | THE CIGNA GROUP | 0.51% | Equity (US) | — |
| BSX | BOSTON SCIENTIFIC CORP | 0.45% | Equity (US) | — |
| REGN | REGENERON PHARMACEUTICALS | 0.40% | Equity (US) | — |
| HCA | HCA HEALTHCARE INC | 0.39% | Equity (US) | — |
| COR | CENCORA INC | 0.35% | Equity (US) | — |
| CAH | CARDINAL HEALTH INC | 0.34% | Equity (US) | — |
| EW | EDWARDS LIFESCIENCES CORP | 0.32% | Equity (US) | — |
| HUM | HUMANA INC | 0.29% | Equity (US) | — |
| IDXX | IDEXX LABORATORIES INC | 0.29% | Equity (US) | — |
| BDX | BECTON DICKINSON AND CO | 0.27% | Equity (US) | — |
| A | AGILENT TECHNOLOGIES INC | 0.24% | Equity (US) | — |
| WAT | WATERS CORP | 0.23% | Equity (US) | — |
| ZTS | ZOETIS INC | 0.22% | Equity (US) | — |
| IQV | IQVIA HOLDINGS INC | 0.20% | Equity (US) | — |
| CNC | CENTENE CORP | 0.20% | Equity (US) | — |
| GEHC | GE HEALTHCARE TECHNOLOGY | 0.19% | Equity (US) | — |
| BIIB | BIOGEN INC | 0.19% | Equity (US) | — |
| DXCM | DEXCOM INC | 0.19% | Equity (US) | — |
| RMD | RESMED INC | 0.18% | Equity (US) | — |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 0.16% | Equity (US) | — |
| WST | WEST PHARMACEUTICAL SERVICES | 0.15% | Equity (US) | — |
| MTD | METTLER-TOLEDO INTERNATIONAL | 0.15% | Equity (US) | — |
| DGX | QUEST DIAGNOSTICS INC | 0.14% | Equity (US) | — |
| LH | LABCORP HOLDINGS INC | 0.14% | Equity (US) | — |
Geographic Breakdown
Fund Holdings
ProShares Ultra Health Care ·
NPORT-P period 2026-05-31
(filed 2026-04-24)
Net assets:
$93M
· 77 total positions
· equity 70.79%
· non-equity 17.86%
| # | Symbol | Issuer | Weight | Value |
|---|---|---|---|---|
| 1 | Eli Lilly & Co. | Eli Lilly & Co. | 10.22% | $9.5M |
| 2 | Johnson & Johnson | Johnson & Johnson | 7.32% | $6.8M |
| 3 | AbbVie, Inc. | AbbVie, Inc. | 5.02% | $4.7M |
| 4 | Merck & Co., Inc. | Merck & Co., Inc. | 3.76% | $3.5M |
| 5 | UnitedHealth Group, Inc. | UnitedHealth Group, Inc. | 3.25% | $3.0M |
| 6 | Amgen, Inc. | Amgen, Inc. | 2.56% | $2.4M |
| 7 | Abbott Laboratories | Abbott Laboratories | 2.48% | $2.3M |
| 8 | Thermo Fisher Scientific, Inc. | Thermo Fisher Scientific, Inc. | 2.40% | $2.2M |
| 9 | Gilead Sciences, Inc. | Gilead Sciences, Inc. | 2.26% | $2.1M |
| 10 | Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | 2.18% | $2.0M |
| 11 | Pfizer, Inc. | Pfizer, Inc. | 1.92% | $1.8M |
| 12 | Stryker Corp. | Stryker Corp. | 1.63% | $1.5M |
| 13 | Danaher Corp. | Danaher Corp. | 1.62% | $1.5M |
| 14 | Bristol-Myers Squibb Co. | Bristol-Myers Squibb Co. | 1.55% | $1.4M |
| 15 | Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | 1.54% | $1.4M |
| 16 | Medtronic plc | Medtronic plc | 1.53% | $1.4M |
| 17 | McKesson Corp. | McKesson Corp. | 1.49% | $1.4M |
| 18 | Boston Scientific Corp. | Boston Scientific Corp. | 1.39% | $1.3M |
| 19 | CVS Health Corp. | CVS Health Corp. | 1.24% | $1.2M |
| 20 | HCA Healthcare, Inc. | HCA Healthcare, Inc. | 1.04% | $965643 |
| 21 | Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | 0.96% | $899702 |
| 22 | Cigna Group (The) | Cigna Group (The) | 0.95% | $883661 |
| 23 | Cencora, Inc. | Cencora, Inc. | 0.88% | $823546 |
| 24 | Elevance Health, Inc. | Elevance Health, Inc. | 0.87% | $811520 |
| 25 | Zoetis, Inc., Class A | Zoetis, Inc. | 0.71% | $659433 |
Showing top 25 of 60 equity holdings.
Non-equity holdings
— 17 positions,
17.86% of NAV
| Category | Weight | Value | Positions |
|---|---|---|---|
| Other | 10.73% | $10.0M | 1 |
| Repurchase agreement | 5.08% | $4.7M | 9 |
| Derivative (equity) | 1.98% | $1.8M | 6 |
| Short-term investment | 0.07% | $67200 | 1 |
Daily issuer data also available
(2026-06-13)
via ETF Constituents
Price History
Seasonality
| Month | Avg Return | Years of Data |
|---|---|---|
| Jan | +0.93% | 19 |
| Feb | -0.35% | 20 |
| Mar | +0.97% | 20 |
| Apr | +1.66% | 20 |
| May | +1.63% | 20 |
| Jun | +2.08% | 20 |
| Jul | +4.04% | 19 |
| Aug | +0.17% | 19 |
| Sep | -1.08% | 19 |
| Oct | +0.09% | 19 |
| Nov | +4.71% | 19 |
| Dec | +0.91% | 19 |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $47.27
SMA 50: $46.09
SMA 200: $47.91
Current: $49.57
EMA 12: $48.42
EMA 26: $47.33
MACD: 1.0936 | Signal: 0.3256
BULLISH
ADX (14): 22.34
WEAK TREND
+DI: 35.51
−DI: 16.75
Momentum Oscillators
RSI (14): 60.41
NEUTRAL
Stoch %K: 85.06
Stoch %D: 86.00
Williams %R: -15.13
Volume & Volatility
BB Upper: $50.85
BB Lower: $43.70
NEUTRAL
OBV: -216,749
Vol SMA 20: 7,237
Vol ROC: 14.27%
ATR: $1.23
True Range: $0.95
HV 20: 35.6%
HV 30: 32.5%
HV 60: 32.2%
Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:19.985000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis
Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.
Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.
News
Options Activity
- IV Rank (30D)
- 39.52
- IV Rank (7D)
- 100
- Avg IV
- 46.2%
- Straddle (30D)
- $4.70
- Straddle (7D)
- $3.15
- P/C Volume
- 2.75
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Volatility Surface
Enter a ticker to render the implied volatility surface.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
- Beta (1Y vs SPY)
- 0.89
- Correlation (SPY)
- 36.3%
- R²
- 0.13
- Ann. Volatility
- 30.3%
- SPY Volatility
- 12.3%
Moderate volatility - stock generally follows market
Beta & Alpha Over Time
Constituent Performance
Click any bar to view the full quote for that stock.
Constituents
| Symbol | Price | 1 Day | 1 Week | 1 Month |
|---|